Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 116 of 116 entries
Sorted by: Best Match Show Resources per page
Rab34 GTPase mediates ciliary membrane formation in the intracellular ciliogenesis pathway.

Current biology : CB

Ganga AK, Kennedy MC, Oguchi ME, Gray S, Oliver KE, Knight TA, De La Cruz EM, Homma Y, Fukuda M, Breslow DK.
PMID: 33989527
Curr Biol. 2021 Jul 12;31(13):2895-2905.e7. doi: 10.1016/j.cub.2021.04.075. Epub 2021 May 13.

The primary cilium is an essential organizing center for signal transduction, and ciliary defects cause congenital disorders known collectively as ciliopathies.

Cite
Ganga AK, Kennedy MC, Oguchi ME, et al. Rab34 GTPase mediates ciliary membrane formation in the intracellular ciliogenesis pathway. Curr Biol. 2021;31(13):2895-2905.e7doi: 10.1016/j.cub.2021.04.075.
Ganga, A. K., Kennedy, M. C., Oguchi, M. E., Gray, S., Oliver, K. E., Knight, T. A., De La Cruz, E. M., Homma, Y., Fukuda, M., & Breslow, D. K. (2021). Rab34 GTPase mediates ciliary membrane formation in the intracellular ciliogenesis pathway. Current biology : CB, 31(13), 2895-2905.e7. https://doi.org/10.1016/j.cub.2021.04.075
Ganga, Anil Kumar, et al. "Rab34 GTPase mediates ciliary membrane formation in the intracellular ciliogenesis pathway." Current biology : CB vol. 31,13 (2021): 2895-2905.e7. doi: https://doi.org/10.1016/j.cub.2021.04.075
Ganga AK, Kennedy MC, Oguchi ME, Gray S, Oliver KE, Knight TA, De La Cruz EM, Homma Y, Fukuda M, Breslow DK. Rab34 GTPase mediates ciliary membrane formation in the intracellular ciliogenesis pathway. Curr Biol. 2021 Jul 12;31(13):2895-2905.e7. doi: 10.1016/j.cub.2021.04.075. Epub 2021 May 13. PMID: 33989527; PMCID: PMC8282722.
Copy Download .nbib Format: NLM
An Introduction to the Benchmarking and Publications for Non-Targeted Analysis Working Group.

Analytical chemistry

Place BJ, Ulrich EM, Challis JK, Chao A, Du B, Favela K, Feng YL, Fisher CM, Gardinali P, Hood A, Knolhoff AM, McEachran AD, Nason SL, Newton SR, Ng B, Nuñez J, Peter KT, Phillips AL, Quinete N, Renslow R, Sobus JR, Sussman EM, Warth B, Wickramasekara S, Williams AJ.
PMID: 34842413
Anal Chem. 2021 Dec 14;93(49):16289-16296. doi: 10.1021/acs.analchem.1c02660. Epub 2021 Nov 29.

Non-targeted analysis (NTA) encompasses a rapidly evolving set of mass spectrometry techniques aimed at characterizing the chemical composition of complex samples, identifying unknown compounds, and/or classifying samples, without prior knowledge regarding the chemical content of the samples. Recent advances...

Cite
Place BJ, Ulrich EM, Challis JK, et al. An Introduction to the Benchmarking and Publications for Non-Targeted Analysis Working Group. Anal Chem. 2021;93(49):16289-16296doi: 10.1021/acs.analchem.1c02660.
Place, B. J., Ulrich, E. M., Challis, J. K., Chao, A., Du, B., Favela, K., Feng, Y. L., Fisher, C. M., Gardinali, P., Hood, A., Knolhoff, A. M., McEachran, A. D., Nason, S. L., Newton, S. R., Ng, B., Nuñez, J., Peter, K. T., Phillips, A. L., Quinete, N., Renslow, R., Sobus, J. R., Sussman, E. M., Warth, B., Wickramasekara, S., & Williams, A. J. (2021). An Introduction to the Benchmarking and Publications for Non-Targeted Analysis Working Group. Analytical chemistry, 93(49), 16289-16296. https://doi.org/10.1021/acs.analchem.1c02660
Place, Benjamin J, et al. "An Introduction to the Benchmarking and Publications for Non-Targeted Analysis Working Group." Analytical chemistry vol. 93,49 (2021): 16289-16296. doi: https://doi.org/10.1021/acs.analchem.1c02660
Place BJ, Ulrich EM, Challis JK, Chao A, Du B, Favela K, Feng YL, Fisher CM, Gardinali P, Hood A, Knolhoff AM, McEachran AD, Nason SL, Newton SR, Ng B, Nuñez J, Peter KT, Phillips AL, Quinete N, Renslow R, Sobus JR, Sussman EM, Warth B, Wickramasekara S, Williams AJ. An Introduction to the Benchmarking and Publications for Non-Targeted Analysis Working Group. Anal Chem. 2021 Dec 14;93(49):16289-16296. doi: 10.1021/acs.analchem.1c02660. Epub 2021 Nov 29. PMID: 34842413.
Copy Download .nbib Format: NLM
NP-MRD: the Natural Products Magnetic Resonance Database.

Nucleic acids research

Wishart DS, Sayeeda Z, Budinski Z, Guo A, Lee BL, Berjanskii M, Rout M, Peters H, Dizon R, Mah R, Torres-Calzada C, Hiebert-Giesbrecht M, Varshavi D, Varshavi D, Oler E, Allen D, Cao X, Gautam V, Maras A, Poynton EF, Tavangar P, Yang V, van Santen JA, Ghosh R, Sarma S, Knutson E, Sullivan V, Jystad AM, Renslow R, Sumner LW, Linington RG, Cort JR.
PMID: 34791429
Nucleic Acids Res. 2022 Jan 07;50:D665-D677. doi: 10.1093/nar/gkab1052.

The Natural Products Magnetic Resonance Database (NP-MRD) is a comprehensive, freely available electronic resource for the deposition, distribution, searching and retrieval of nuclear magnetic resonance (NMR) data on natural products, metabolites and other biologically derived chemicals. NMR spectroscopy has...

Cite
Wishart DS, Sayeeda Z, Budinski Z, et al. NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic Acids Res. 2022;50:D665-D677doi: 10.1093/nar/gkab1052.
Wishart, D. S., Sayeeda, Z., Budinski, Z., Guo, A., Lee, B. L., Berjanskii, M., Rout, M., Peters, H., Dizon, R., Mah, R., Torres-Calzada, C., Hiebert-Giesbrecht, M., Varshavi, D., Varshavi, D., Oler, E., Allen, D., Cao, X., Gautam, V., Maras, A., Poynton, E. F., Tavangar, P., Yang, V., van Santen, J. A., Ghosh, R., Sarma, S., Knutson, E., Sullivan, V., Jystad, A. M., Renslow, R., Sumner, L. W., Linington, R. G., & Cort, J. R. (2022). NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic acids research, 50D665-D677. https://doi.org/10.1093/nar/gkab1052
Wishart, David S, et al. "NP-MRD: the Natural Products Magnetic Resonance Database." Nucleic acids research vol. 50 (2022): D665-D677. doi: https://doi.org/10.1093/nar/gkab1052
Wishart DS, Sayeeda Z, Budinski Z, Guo A, Lee BL, Berjanskii M, Rout M, Peters H, Dizon R, Mah R, Torres-Calzada C, Hiebert-Giesbrecht M, Varshavi D, Varshavi D, Oler E, Allen D, Cao X, Gautam V, Maras A, Poynton EF, Tavangar P, Yang V, van Santen JA, Ghosh R, Sarma S, Knutson E, Sullivan V, Jystad AM, Renslow R, Sumner LW, Linington RG, Cort JR. NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic Acids Res. 2022 Jan 07;50:D665-D677. doi: 10.1093/nar/gkab1052. PMID: 34791429.
Copy Download .nbib Format: NLM
The power of genomic estimated breeding values for selection when using a finite population size in genetic improvement of tetraploid potato.

G3 (Bethesda, Md.)

Selga C, Reslow F, Pérez-Rodríguez P, Ortiz R.
PMID: 34849763
G3 (Bethesda). 2021 Oct 21; doi: 10.1093/g3journal/jkab362. Epub 2021 Oct 21.

Potato breeding relies heavily on visual phenotypic scoring for clonal selection. Obtaining robust phenotypic data can be labor intensive and expensive, especially in the early cycles of a potato breeding program where the number of genotypes is very large....

Cite
Selga C, Reslow F, Pérez-Rodríguez P, et al. The power of genomic estimated breeding values for selection when using a finite population size in genetic improvement of tetraploid potato. G3 (Bethesda). 2021;doi: 10.1093/g3journal/jkab362.
Selga, C., Reslow, F., Pérez-Rodríguez, P., & Ortiz, R. (2021). The power of genomic estimated breeding values for selection when using a finite population size in genetic improvement of tetraploid potato. G3 (Bethesda, Md.), . https://doi.org/10.1093/g3journal/jkab362
Selga, Catja, et al. "The power of genomic estimated breeding values for selection when using a finite population size in genetic improvement of tetraploid potato." G3 (Bethesda, Md.) vol. (2021). doi: https://doi.org/10.1093/g3journal/jkab362
Selga C, Reslow F, Pérez-Rodríguez P, Ortiz R. The power of genomic estimated breeding values for selection when using a finite population size in genetic improvement of tetraploid potato. G3 (Bethesda). 2021 Oct 21; doi: 10.1093/g3journal/jkab362. Epub 2021 Oct 21. PMID: 34849763.
Copy Download .nbib Format: NLM
Toward Nonbinary Nuance in Research and Care: Mapping Differences in Gender Affirmation and Transgender Congruence in an Online National U.S. Survey.

Transgender health

Breslow AS, Wojcik H, Cox R, Tran NM, Brewster ME.
PMID: 34159259
Transgend Health. 2021 Jun 02;6(3):156-163. doi: 10.1089/trgh.2020.0038. eCollection 2021 Jun.

No abstract available.

Cite
Breslow AS, Wojcik H, Cox R, et al. Toward Nonbinary Nuance in Research and Care: Mapping Differences in Gender Affirmation and Transgender Congruence in an Online National U.S. Survey. Transgend Health. 2021;6(3):156-163doi: 10.1089/trgh.2020.0038.
Breslow, A. S., Wojcik, H., Cox, R., Tran, N. M., & Brewster, M. E. (2021). Toward Nonbinary Nuance in Research and Care: Mapping Differences in Gender Affirmation and Transgender Congruence in an Online National U.S. Survey. Transgender health, 6(3), 156-163. https://doi.org/10.1089/trgh.2020.0038
Breslow, Aaron S, et al. "Toward Nonbinary Nuance in Research and Care: Mapping Differences in Gender Affirmation and Transgender Congruence in an Online National U.S. Survey." Transgender health vol. 6,3 (2021): 156-163. doi: https://doi.org/10.1089/trgh.2020.0038
Breslow AS, Wojcik H, Cox R, Tran NM, Brewster ME. Toward Nonbinary Nuance in Research and Care: Mapping Differences in Gender Affirmation and Transgender Congruence in an Online National U.S. Survey. Transgend Health. 2021 Jun 02;6(3):156-163. doi: 10.1089/trgh.2020.0038. eCollection 2021 Jun. PMID: 34159259; PMCID: PMC8215399.
Copy Download .nbib Format: NLM
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release.

Journal for immunotherapy of cancer

Dang K, Castello G, Clarke SC, Li Y, Balasubramani A, Boudreau A, Davison L, Harris KE, Pham D, Sankaran P, Ugamraj HS, Deng R, Kwek S, Starzinski A, Iyer S, van Schooten W, Schellenberger U, Sun W, Trinklein ND, Buelow R, Buelow B, Fong L, Dalvi P.
PMID: 34088740
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002488.

BACKGROUND: Therapeutic options currently available for metastatic castration-resistant prostate cancer (mCRPC) do not extend median overall survival >6 months. Therefore, the development of novel and effective therapies for mCRPC represents an urgent medical need. T cell engagers (TCEs) have...

Cite
Dang K, Castello G, Clarke SC, et al. Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. J Immunother Cancer. 2021;9(6)doi: 10.1136/jitc-2021-002488.
Dang, K., Castello, G., Clarke, S. C., Li, Y., Balasubramani, A., Boudreau, A., Davison, L., Harris, K. E., Pham, D., Sankaran, P., Ugamraj, H. S., Deng, R., Kwek, S., Starzinski, A., Iyer, S., van Schooten, W., Schellenberger, U., Sun, W., Trinklein, N. D., Buelow, R., Buelow, B., Fong, L., & Dalvi, P. (2021). Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. Journal for immunotherapy of cancer, 9(6), . https://doi.org/10.1136/jitc-2021-002488
Dang, Kevin, et al. "Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release." Journal for immunotherapy of cancer vol. 9,6 (2021). doi: https://doi.org/10.1136/jitc-2021-002488
Dang K, Castello G, Clarke SC, Li Y, Balasubramani A, Boudreau A, Davison L, Harris KE, Pham D, Sankaran P, Ugamraj HS, Deng R, Kwek S, Starzinski A, Iyer S, van Schooten W, Schellenberger U, Sun W, Trinklein ND, Buelow R, Buelow B, Fong L, Dalvi P. Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002488. PMID: 34088740; PMCID: PMC8183203.
Copy Download .nbib Format: NLM
NP-MRD: the Natural Products Magnetic Resonance Database.

Nucleic acids research

Wishart DS, Sayeeda Z, Budinski Z, Guo A, Lee BL, Berjanskii M, Rout M, Peters H, Dizon R, Mah R, Torres-Calzada C, Hiebert-Giesbrecht M, Varshavi D, Varshavi D, Oler E, Allen D, Cao X, Gautam V, Maras A, Poynton EF, Tavangar P, Yang V, van Santen JA, Ghosh R, Sarma S, Knutson E, Sullivan V, Jystad AM, Renslow R, Sumner LW, Linington RG, Cort JR.
PMID: 34791429
Nucleic Acids Res. 2021 Nov 17; doi: 10.1093/nar/gkab1052. Epub 2021 Nov 17.

The Natural Products Magnetic Resonance Database (NP-MRD) is a comprehensive, freely available electronic resource for the deposition, distribution, searching and retrieval of nuclear magnetic resonance (NMR) data on natural products, metabolites and other biologically derived chemicals. NMR spectroscopy has...

Cite
Wishart DS, Sayeeda Z, Budinski Z, et al. NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic Acids Res. 2021;doi: 10.1093/nar/gkab1052.
Wishart, D. S., Sayeeda, Z., Budinski, Z., Guo, A., Lee, B. L., Berjanskii, M., Rout, M., Peters, H., Dizon, R., Mah, R., Torres-Calzada, C., Hiebert-Giesbrecht, M., Varshavi, D., Varshavi, D., Oler, E., Allen, D., Cao, X., Gautam, V., Maras, A., Poynton, E. F., Tavangar, P., Yang, V., van Santen, J. A., Ghosh, R., Sarma, S., Knutson, E., Sullivan, V., Jystad, A. M., Renslow, R., Sumner, L. W., Linington, R. G., & Cort, J. R. (2021). NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic acids research, . https://doi.org/10.1093/nar/gkab1052
Wishart, David S, et al. "NP-MRD: the Natural Products Magnetic Resonance Database." Nucleic acids research vol. (2021). doi: https://doi.org/10.1093/nar/gkab1052
Wishart DS, Sayeeda Z, Budinski Z, Guo A, Lee BL, Berjanskii M, Rout M, Peters H, Dizon R, Mah R, Torres-Calzada C, Hiebert-Giesbrecht M, Varshavi D, Varshavi D, Oler E, Allen D, Cao X, Gautam V, Maras A, Poynton EF, Tavangar P, Yang V, van Santen JA, Ghosh R, Sarma S, Knutson E, Sullivan V, Jystad AM, Renslow R, Sumner LW, Linington RG, Cort JR. NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic Acids Res. 2021 Nov 17; doi: 10.1093/nar/gkab1052. Epub 2021 Nov 17. PMID: 34791429.
Copy Download .nbib Format: NLM
Antibodies to PCSK9: a superior way to lower LDL cholesterol?.

Circulation research

Maxwell KN, Breslow JL.
PMID: 22821907
Circ Res. 2012 Jul 20;111(3):274-7. doi: 10.1161/CIRCRESAHA.112.275859.

Lowering of LDL cholesterol, predominantly accomplished clinically by statins, is one of the key components of both the prevention and medical management of coronary atherosclerosis; however, additional or alternative cholesterol lowering agents are needed for patients who fail to...

Cite
Maxwell KN, Breslow JL. Antibodies to PCSK9: a superior way to lower LDL cholesterol?. Circ Res. 2012;111(3):274-7doi: 10.1161/CIRCRESAHA.112.275859.
Maxwell, K. N., & Breslow, J. L. (2012). Antibodies to PCSK9: a superior way to lower LDL cholesterol?. Circulation research, 111(3), 274-7. https://doi.org/10.1161/CIRCRESAHA.112.275859
Maxwell, Kara N, and Breslow, Jan L. "Antibodies to PCSK9: a superior way to lower LDL cholesterol?." Circulation research vol. 111,3 (2012): 274-7. doi: https://doi.org/10.1161/CIRCRESAHA.112.275859
Maxwell KN, Breslow JL. Antibodies to PCSK9: a superior way to lower LDL cholesterol?. Circ Res. 2012 Jul 20;111(3):274-7. doi: 10.1161/CIRCRESAHA.112.275859. PMID: 22821907.
Copy Download .nbib Format: NLM
Showing 109 to 116 of 116 entries